OLV on the HILL: Women in Innovation
On April 3rd, Exec. Director Robin Rasor testified before the Senate Subcommittee on IP about the uniqueness of Duke’s model and how to encourage and retain women in STEM.
INTERNATIONAL WOMAN'S DAY
to Checkmate Cancer
Gavilán Biodesign's ability to out-maneuver resistance, using AI technology to specially design drugs, has the potential to change the way drugs are made.
AskBio: 1st Patient in Phase
1/2 Study–Pompe Disease
Initial clinical study to evaluate ACTUS-101 over 52 weeks that could improve quality of life for those who are affected with rare genetic disorder - Pompe Disease.
TECH TRANSFER NEWS
Our 2018 Annual Report has arrived!
Discover the incredible things the Duke Office of Licensing and Ventures is accomplishing.
BY THE NUMBERS
The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University